MS

The Race To Cure Multiple Sclerosis
Seeking Alpha
Thu, 07/5/12 - 01:12 pm
MS
multiple sclerosis
Biogen Idec
Elan
Novartis
Pfizer
Sanofi
Teva Pharmaceuticals
Bayer
Even With Teva's Patent Ruling, The Company Is Only Covered Until 2015
Seeking Alpha
Mon, 06/25/12 - 11:22 am
Teva Pharmaceuticals
patents
Mylan
Momenta
Natco
Acorda Therapeutics
Copaxone
MS
multiple sclerosis
Teva announces results from GALA Phase III trial in MS
The Fly on the Wall
Thu, 06/14/12 - 08:19 am
Teva Pharmaceuticals
MS
multiple sclerosis
glatiramer acetate
Genzyme seeks approvals for MS drug
Boston Globe, MA
Wed, 06/13/12 - 12:55 pm
MS
multiple sclerosis
Genzyme
Sanofi
Lemtrada
Your Warning Label Is My Sales Brochure
Motley Fool
Thu, 05/17/12 - 10:20 am
warnings
MS
Gilenya
multiple sclerosis
Novartis
Biogen Idec
Bayer
Teva Pharmaceuticals
Elan
Pfizer
New Caution Urged Over Sole Oral MS Drug On the Market
WSJ Online
Tue, 05/15/12 - 10:30 am
MS
multiple sclerosis
Novartis
Gilenya
FDA
FDA Warns MS Patients Against Unproven Stent Procedure
Thu, 05/10/12 - 09:45 pm
FDA
patient
MS
stent
FDA Warns MS Patients Against Unproven Stent Procedure
Thu, 05/10/12 - 09:45 pm
FDA
patient
MS
stent
Biogen Says Data Highlight Safety Profile For BG-12 MS Drug
FOX Business
Tue, 04/24/12 - 10:27 am
Biogen Idec
BG-12
multiple sclerosis
MS
Novartis confirms positive benefit-risk profile of Gilenya following CHMP review
The Fly on the Wall
Fri, 04/20/12 - 10:38 am
CHMP
Novartis
MS
multiple sclerosis
Novartis MS Patient Develops Rare Brain Disease
Pharmalot
Fri, 04/13/12 - 09:57 am
Gilenya
MS
multiple sclerosis
PML
Novartis
Watchdog says FDA should consider restricting Gilenya
Fierce Pharma
Fri, 04/6/12 - 11:50 am
FDA
Gilenya
Novartis
multiple sclerosis
MS
BrainStorm Cell initiates study for MS
The Fly on the Wall
Mon, 03/12/12 - 05:28 pm
MS
multiple sclerosis
BrainStorm Cell Therapeutics
stem cells
Sanofi faces uphill struggle in MS drug market
Reuters, UK
Mon, 02/6/12 - 11:50 am
MS
multiple sclerosis
Sanofi
Novartis
Biogen Idec: The Patriots of Biotechs
PharmExec
Thu, 02/2/12 - 11:06 am
Biogen Idec
Tysabri
Elan
biotech
BG-12
MS
multiple sclerosis
Tysabri label change could add $1B to sales
Fierce Pharma
Mon, 01/23/12 - 12:00 pm
Tysabri
MS
multiple sclerosis
Biogen Idec
Novartis falls 4% on MS drug concerns
Marketwatch
Fri, 01/20/12 - 12:19 pm
MS
Novartis
Gilenya
multiple sclerosis
Novartis’s Gilenya Reviewed After 11 Deaths
Bloomberg
Fri, 01/20/12 - 10:06 am
Novartis
Gilenya
MS
multiple sclerosis
EMA
Questcor: A Mid Cap Bio-Pharma With Bullish Indicators
Seeking Alpha
Tue, 01/17/12 - 10:26 am
Questcor
lupus
nephrotic syndrome
infantile spasms
MS
multiple sclerosis
H.P. Acthar Gel
Sanofi Says MS Pill Aubagio Fails to Beat Rebif in Trial
Bloomberg
Tue, 12/20/11 - 10:23 am
Sanofi
MS
Aubagio
Rebif
multiple sclerosis
Merck KGaA

Pages